CDC data to 7 Nov 2026 (week 44) · provisional · updates weekly
As of the week ending 7 November 2026, New Jersey has reported 23 mpox (monkeypox) cases in 2026, compared with 30 by the same point in 2025 and 32 in all of 2025. That ranks 15th among US states and territories, or 2.5 cases per million residents. In the last 8 weeks 11 cases were added, against 5 in the 8 weeks before.
Weekly mpox cases: New Jersey
Cases added each week, 2025–2026 (CDC, provisional)
Weekly mpox cases in New Jersey.
US mpox cases by state
1,500 cases in 2026 so far vs 2,128 by this point in 2025
| State | 2026 to date | Per 1M | 2025 same period | Latest week |
|---|---|---|---|---|
| California | 513 | 13.1 | 352 | 21 |
| New York | 220 | 11.1 | 379 | 9 |
| Florida | 116 | 5.3 | 92 | 2 |
| Massachusetts | 53 | 7.6 | 47 | 0 |
| Nevada | 51 | 16.2 | 6 | 3 |
| Arizona | 49 | 6.7 | 0 | 4 |
| Illinois | 46 | 3.6 | 202 | 6 |
| Colorado | 45 | 7.7 | 21 | 1 |
| Ohio | 35 | 3.0 | 23 | 0 |
| Texas | 33 | 1.1 | 260 | 1 |
| Georgia | 27 | 2.5 | 103 | 0 |
| Rhode Island | 27 | 24.6 | 5 | 3 |
| Minnesota | 25 | 4.4 | 18 | 0 |
| Pennsylvania | 25 | 1.9 | 45 | 6 |
| New Jersey | 23 | 2.5 | 30 | 0 |
| Maryland | 22 | 3.6 | 69 | 0 |
| Virginia | 20 | 2.3 | 32 | 1 |
| North Carolina | 18 | 1.7 | 34 | 0 |
| Connecticut | 15 | 4.2 | 13 | 1 |
| Kentucky | 12 | 2.7 | 10 | 2 |
| Tennessee | 11 | 1.6 | 48 | 0 |
| Indiana | 10 | 1.5 | 10 | 0 |
| Oregon | 10 | 2.4 | 19 | 0 |
| Washington | 10 | 1.3 | 123 | 0 |
| South Carolina | 9 | 1.7 | 12 | 5 |
| Wisconsin | 7 | 1.2 | 6 | 1 |
| Maine | 6 | 4.4 | 0 | 0 |
| Missouri | 6 | 1.0 | 13 | 0 |
| Alabama | 5 | 1.0 | 15 | 0 |
| Michigan | 4 | 0.4 | 20 | 0 |
| New Mexico | 4 | 1.9 | 2 | 0 |
| Utah | 4 | 1.2 | 1 | 0 |
| Idaho | 3 | 1.6 | 2 | 0 |
| Puerto Rico | 3 | 0.9 | 9 | 0 |
| Mississippi | 2 | 0.7 | 0 | 0 |
| Oklahoma | 2 | 0.5 | 8 | 0 |
| Alaska | 1 | 1.4 | 1 | 0 |
| Kansas | 1 | 0.3 | 2 | 0 |
| Montana | 1 | 0.9 | 0 | 0 |
| New Hampshire | 1 | 0.7 | 4 | 0 |
| Arkansas | 0 | 0.0 | 0 | 0 |
| Delaware | 0 | 0.0 | 0 | 0 |
| District Of Columbia | 0 | 0.0 | 0 | 0 |
| Hawaii | 0 | 0.0 | 1 | 0 |
| Iowa | 0 | 0.0 | 2 | 0 |
| Louisiana | 0 | 0.0 | 43 | 0 |
| Nebraska | 0 | 0.0 | 1 | 0 |
| North Dakota | 0 | 0.0 | 0 | 0 |
| South Dakota | 0 | 0.0 | 0 | 0 |
| Vermont | 0 | 0.0 | 1 | 0 |
| West Virginia | 0 | 0.0 | 1 | 0 |
| Wyoming | 0 | 0.0 | 0 | 0 |
Mpox in New Jersey: frequently asked questions
How many mpox cases are there in New Jersey in 2026?
New Jersey has reported 23 mpox cases in 2026 as of the week ending 7 November 2026, according to provisional CDC data, 23% fewer than the 30 reported by the same point in 2025.
Are mpox cases rising in New Jersey?
11 cases were added in the last 8 weeks, up from 5 in the previous 8 weeks. The weekly chart on this page shows the full trend since January 2025.
How many mpox cases were there in New Jersey in 2025?
New Jersey reported 32 mpox cases in 2025 (CDC provisional year-end total).
How does New Jersey compare with other states?
New Jersey ranks 15th of 52 US states and territories by mpox cases in 2026, with 2.5 cases per million residents against a national rate of about 4.4. The United States as a whole has reported 1,500 cases in 2026.
Where can I get an mpox vaccine in New Jersey?
The JYNNEOS (MVA-BN) vaccine is available in the US through many doctors, pharmacies, sexual health clinics and local health departments. It is given as two doses four weeks apart. Contact your healthcare provider or the New Jersey health department to find a location near you.
Where does the New Jersey mpox data come from?
Figures come from the CDC National Notifiable Diseases Surveillance System (NNDSS) weekly tables and are provisional: cases can be added later as reports arrive. This page checks for new data every 2 hours.